Press Release – Australia: Creso Pharma makes history as first ASX-listed psychedelics stock

CANNANNEW REPORT

Creso’s acquisition of Halucenex Ltd exposes Australian investors to a market opportunity estimated to be worth US$100 billion. Creso Pharmaceuticals… Read More…..

Excerpt only …
READ MORE BELOW
Source : Press Release – Australia: Creso Pharma makes history as first ASX-listed psychedelics stock

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.